Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors

NCT00086528 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kadmon Corporation, LLC